Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic

  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

143.92 -0.44 (-0.30%)
Streaming Delayed Price Updated: 12:39 PM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina Inc

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
29 30 Next >
Illumina Stock Crumbles As Earnings Guidance Completely Misses Forecasts
Illumina beat second-quarter expectations, but earnings guidance completely missed. 
Via Investor's Business Daily
US Stocks Walk Inflation Tightrope As Futures Point To Cautious Recovery: Why This Analyst Downplays Fed Rate Worries
Stocks could recover on Wednesday from Thursday's weakness, spearheaded by tech and financial stocks, but traders could show restraint. 
Via Benzinga
BNGO Stock Alert: Bionano Just Reverse Split Its Stock
Bionano was a hot genetic analysis stock two years ago but now needed a reverse split so that BNGO stock could stay listed on the Nasdaq. 
Via InvestorPlace
(ILMN) - Analyzing Illumina's Short Interest
Via Benzinga
Week In Review: Pyrotech Closes $97 Million Series A Round For Immunomodulator Drugs
Beijing’s Pyrotech Therapeutics completed a $97 million Series A funding to develop novel small molecule drugs that modulate immune responses for autoimmune diseases. Meanwhile, Mirxes Holding closed a... 
Via Talk Markets
$100 Invested In Illumina 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Looking Into Illumina's Recent Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years
Via Benzinga
Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil
There is opportunity in a crisis. Key biotech stocks amid turmoil could be the greatest deals on the market today. 
Via InvestorPlace
Agrigenomics Market Is Booming Worldwide : Illumina, LGC, Eurofins USA
Stay up-to-date with Agrigenomics Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Exposures COVID-19
Next Generation Sequencing Market Projected to Show Strong Growth : Life Technology, Biomatters, CLC Bio, GATC Biotech
Get an extensive Next Generation Sequencing Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry. 
Via SBWire
Analyst Expectations for Illumina's Future
Via Benzinga
What Does Illumina's Debt Look Like?
Via Benzinga
Looking Into Illumina's Recent Short Interest
Via Benzinga
Illumina Unusual Options Activity For June 28
Via Benzinga
Jim Cramer Says It's Time To Buy This Financial Services Stock Down 32% YTD
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Illumina, Inc. (NASDAQ: ILMN) is not even as good as Danaher Corporation (NYSE: DHR). 
Via Benzinga
Shady Business: 3 Well-Known Stocks That Deserve to Be on Your Blacklist
Corporate America is littered with popular companies that have been fined for running afoul of the law. Here are three shady stocks to avoid. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
A Comprehensive Study Exploring Viral Disease Diagnosis Market : Key Players BioMerieux, Prescient Medicine Holdings, Danaher
AMA released Viral Disease Diagnosis Market research study .Check what differences transitions in customer choices may bring? 
Via SBWire
Exposures COVID-19
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $140 Thousand Today
Via Benzinga
Illumina's CEO Was Just Ousted: Should Investors Buy In Now or Steer Clear?
Things aren't looking up just yet. 
Via The Motley Fool
Disney Considers Different Strategies For Star India, Broadcom Wins Conditional European Approval For VMware Deal, Google Deprioritizes Gen Z Chatbot App: Today's Top Stories
Wall Street Journal 
Via Benzinga
Illumina Slapped With €400M In Fines: European Commission Penalizes Company For Hasty Grail Deal
The European Commission has fined Illumina Inc (NASDAQ: ILMN) and Grail Inc approximately €432 million and €1,000, respectively, for implementing their proposed merger before approval by the... 
Via Benzinga
Did Carl Icahn Just Save IEP Stock?
Hindenberg forced Icahn to disentangle his loans from the company, another victory for the short seller's research report. 
Via InvestorPlace
Breather For Carl Icahn: Revised Loan Agreements and Recovery Strategy Post Short-Seller Attack
Activist investor Carl Icahn has been struggling to recover after a short-seller attack led to a 40% drop in his investment company's shares, Icahn Enterprises L.P. (NASDAQ: IEP), alarming major banks... 
Via Benzinga
Creative Biolabs’ Innovative Microbial Identification Solutions Propel Live Biotherapeutic Research
Via Get News
Illumina Announces Job Layoffs After CEO Resignation, Icahn's Board Chess Game: What's Next?
Biotechnology company Illumina, Inc. (NASDAQ: ILMN) initiated layoffs within its research and development (R&D) team, affecting approximately 10% of that staff. 
Via Benzinga
S&P 500: Carnival, Tesla Headline Big-Cap Losers Monday
Carnival rebounded from its 21-day, while Tesla is tumbling toward it. 
Via Investor's Business Daily
CEO Shuffle: 7 Stocks That Could Gain Momentum From New Leadership
New CEOs and other top managers can revitalize companies. For example, here are seven stocks to gain momentum from leadership changes. 
Via InvestorPlace
Medical Stocks Waters, Agilent, Illumina Show Growth Potential
Medical-sector stocks Waters, Agilent, and Illumina appear to be trading at low valuations relative to their future growth prospects, according to analysts. 
Via MarketBeat
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.